Medical device company Amplitude Vascular Systems (AVS) has announced the completion of a $36m Series B financing round to support the peripheral commercial launch of its Pulse intravascular ...

At Fierce Healthcare, we keep track of all the venture capital being funneled into the health tech and digital health ...

Amplitude Vascular Systems (AVS), a medical device company focused on safely and effectively treating severely calcified arterial disease with its nov ...

multi-center study evaluating the technical and clinical success of the PULSE IVL™ System for treating patients with calcific femoropopliteal arteries. The study will enroll up to 120 patients ...

POWER PAD II is a prospective, single-arm, multicenter study evaluating the technical and clinical success of the PIVL system for treating patients with calcific femoropopliteal arteries. The study ...

Dr. Langhoff: Atherectomy offers treatment options for a broad spectrum of indications to treat various lesion pathologies, primarily in the femoropopliteal arteries. Atherectomy often comes into ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new study says. Infection with the COVID-19 virus is associated with rapid ...